Home >

Colombian Group of Psoriasis and Psoriatic Arthritis (ColPsor)

2012/10/26 - News from medical groups


The Colombian Group of Psoriasis and Psoriatic Arthritis (ColPsor) is a non-profit study group gathering dermatologists and rheumatologists interested in promoting psoriasis knowledge and in improving the quality of life of patients suffering from these pathologies.

ColPsor is endorsed by the Colombian Association of Dermatology and Dermatologic Surgery (Asocolderma), it is a part of the Latin American Society of Psoriasis (Solapso) and it support de Colombian Foundation of Patients with Psoriasis (Fundapso).


Tha main interest of ColPsor is to encourage dermatologists, rheumatologists, internists, patients and the scientific community as a whole to generate together information on the behavior of the disease in our environment and thus promote an interdisciplinary and participative debate on topics favoring the comprehensive management of psoriasis.

ColPsor is composed of opinion leaders in psoriasis from all over Colombia and it is open to new members and to doctors who share ColPsor’s academic interests.

Academic endorsements

ColPsor is part of the Solapso and its delegates to the organization are members of the executive committee of the ColPsor. Solapso fully supports the academic activities of ColPsor, which is the reason why only ColPsor is authorised to organise the Solapso’s regional activities in Colombia.

Fundapso has solicited technical and scientific advice from ColPsor’s members in order to provide support and therapeutic education to psoriatic patients. As a result, dermatologists and rheumatologists from ColPsor are members of Fundapso’s scientific committee.


During the last 2 years, ColPsor has organized scientific events, supported by Asocolderma, destined to share advances in the understanding of psoriasis with dermatology and rheumatology residents, internists, and dermatologists and rheumatologists from all over Colombia. In the same way, we have promoted and supported events for patients organized by Fundapso.

1st ColPsor meeting

  • Bogotá, May 8, 2010
    2nd ColPsor meeting
  • Medellín, July 23, 2011
    3rd ColPsor meeting
  • Cali, September 24, 2011
    Solapso Symposium "Advances in the understanding of psoriasis: a new perspective" at XXVIII National Dermatology and Dermatologic Surgery Congress & XVI ATD International
  • Bogotá, Colombia. September 17, 2010
    1st Colombian-Venezuelan Solapso Symposium at XLVII VENEZUELA CONGRESS OF DERMATOLOGY
  • Valencia, Venezuela. November 10-12, 2011
    2nd Colombian-Venezuelan Solapso Symposium at XXIX Dermatology and Dermatologic Surgery Congress
  • Armenia, Colombia, August 4, 2012


a. Scientific Articles

  • González C. Psoriasis, implicaciones laborales. Revista de la Sociedad Colombiana de Medicina del Trabajo. 2004; 7:26-30
  • González C, Castro L, Gutiérrez L, Rodríguez V, Londoño J, Santos AM, Escobar A, Valle R. Comportamiento epidemiológico y clínico de la Psoriasis en la Población Colombiana. Rev Colomb Reumatol. 2005; 12: 278 - 278
  • Candia L, Márquez J, González C, Santos AM, Londoño J, Valle R, Zabaleta J, Yaqub Z, Espinoza LR. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. J Clin Rheumatol. 2006; 12:226-9.
  • Fonseca D, Castro L, González C, Aristizabal. L, Cruz C, Sánchez X et al. Inmunología y terapia biológica en psoriasis. Rev Asoc Colomb Dermatol 2007;03: 208-18
  • González C, Castro L, De la Cruz G, Arenas C, Beltrán A, Santos AM. Caracterización epidemiológica de la Psoriasis en el Hospital Militar Central. Rev Asoc Colomb Dermatol 2009; 17: 11 - 17.
  • Sierra C, Velásquez M. Psoriasis: revisión del tema con énfasis en la inmunopatogénesis. Iatrea. 2009;(22) No 3:272-83
  • Fernández D, Beltrán A, Londoño J, Reyes E, Mora C, Santos P, Candia L, Valle R. Diagnóstico de Artritis Psoriática. Rev Colomb Reumatol.2009; 16: 342-351
  • Ruiz C, González Z, Jiménez SB, Velásquez M. Diagnóstico de la tuberculosis latente en la era de la terapia biológica. Rev Asoc Colomb Dermatol. 2010;18: 139-48
  • González C, Castro L, Velásquez M, Londoño A, Echeverri MA, Hernández N, et al. Ustekinumab. Rev Asoc Colomb Dermatol 2010; 17: s.1-28
  • Vélez N, Bohórquez L, Corrales MF, Orrego S, Jiménez SB, Zuluaga de Cadena A, et al. Caracterización de los pacientes con psoriasis en tratamiento con fototerapia. Rev Asoc Colomb Dermatol. 2011; 19:100-6.
    b. Posters
  • González G, Castro L, Londoño A, Vargas M, Sánchez X. Terapia biológica en Psoriasis, Experiencia con Etanercept en Colombia, serie de casos. Póster. XXVII Congreso Nacional de Dermatología y Cirugía Dermatológica. 2008.
  • González G, Castro L, Londoño A, Vargas M, Sánchez X. Terapia biológica en Psoriasis, Experiencia con Infliximab en Colombia, serie de casos. Póster. XXVII Congreso nacional de dermatología y cirugía dermatológica. 2008.
  • Castro L, González C, Avellaneda C Beltrán A, Manrique G, Fernández D, et al. Ejercicio de aplicación de una encuesta de tamizaje para artritis psoriática en pacientes con psoriasis. Póster. XXVIII Congreso nacional de dermatología y cirugía dermatológica. 2010.
  • Varela J, Castro L, González C, 1 Londoño J, Beltrán A, Bautista W, Valle- Oñate R. Prevalence of Psoriatic Arthritis in patients with Psoriasis. GRAPPA Annual Meeting Trainees Symposium, Miami. Dec 2010
  • Castro L, González C, Amador J, Castañeda A et al. Endothelial dysfunction, cardiovascular risk factors, and metabolic syndrome in a cohort of patients with psoriasis in the "Hospital Militar Central de Colombia. Poster, GRAPPA Annual Meeting Trainees Symposium, Miami. Dec 2010
    c. Books

  • Chalela JG, González C, Castro L, et al. Guías Colombianas de Psoriasis. Consenso Colombiano. Editorial Nomos. 2008
  • 1er Consenso Latinoamericano de Psoriasis. Rio de Janeiro, Brasil. 2009 en www.solapso.org/archivos/LATINOAMERICANO-1_2009.pdf
  • González C, Londoño A, Castro L, et al. Guías basadas en la evidencia para el manejo de la psoriasis en Colombia. Editorial Panamericana. 2012

    National Coordinators

Bogotá: Cesar González, Luis Castro, Adriana Beltrán

Medellín: Angela Londoño, Margarita Velásquez, Oscar Felipe

Cali: Myriam Vargas, Lucy García

Costa Atlántica: Esperanza Meléndez

Eje cafetero: Angela Seidel

Corporate Image

Colombian Group of Psoriasis and Psoriatic Arthritis, ColPsor


Key concepts: Movement, Surmount, Optimism

This symbol is, on one hand, the abstract representation of some characteristics of psoriasis; on the other hand it communicates some concepts one wishes to relate to the ColPsor group, such as movement and optimism.

The bottom curve line represents the skin surface; the smaller elements, seeming to advance towards the top are the graphic representation of the scales that usually appear when the cells accumulate in the surface. The psoriasis is represented by the graphic elements that move towards the right.

In another way, the graphic elements that appear toward the top also represent a group, union of people wanting to progress a move forward; they transmit strength and dynamism. As such, the same characteristics of the disease make way for something positive; one should not hide the psoriasis but speak of it with clarity in order to surmount it.

Abbreviated name

Colombian Group of Psoriasis and Psoriatic Arthritis

To make it easy to recognize the group, an abbreviated form of the group’s name was created, using the first part of the most significant names of the group’s name, Colombia and psoriasis, as to create the short name of ColPsor.


Color of Corporate Image

The used colors are black, grey and orange. The color orange was chosen because it conveys vitality, life and optimism.


Cesar González: drcesargonzalez@yahoo.com.ar


SPIN Presentation


Follow us